Journey Strategic Wealth’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.4K Buy
10,448
+96
+0.9% +$501 ﹤0.01% 814
2025
Q4
$51.8K Buy
+10,352
New +$53.9K ﹤0.01% 756
2025
Q3
Sell
-20,402
Closed -$87.9K 755
2025
Q2
$87.9K Buy
20,402
+258
+1% +$1.27K ﹤0.01% 650
2025
Q1
$121K Buy
20,144
+6,184
+44% +$31.3K ﹤0.01% 487
2024
Q4
$55.1K Sell
13,960
-14,235
-50% -$63.8K ﹤0.01% 495
2024
Q3
$165K Sell
28,195
-4,781
-14% -$23.6K 0.01% 487
2024
Q2
$142K Sell
32,976
-4,356
-12% -$20.9K 0.01% 384
2024
Q1
$175K Buy
37,332
+23,413
+168% +$89.6K 0.01% 296
2023
Q4
$68.3K Buy
+13,919
New +$68.2K ﹤0.01% 227

Other funds holding MPT

Journey Strategic Wealth's MPT Position: Q1 2026 in Review

Journey Strategic Wealth increased its Medical Properties Trust (MPT) stake by 0.93% in Q1 2026, buying an estimated $501 and bringing the position to 10,448 shares worth $48.4K. The position accounts for ﹤0.01% of the portfolio, ranked #814.

Journey Strategic Wealth first reported a position in MPT in Q4 2023 and has held it in 9 quarters since. The position peaked at $175K in Q1 2024. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Journey Strategic Wealth held 10,448 shares of Medical Properties Trust worth $48.4K as of Q1 2026.
  • Journey Strategic Wealth bought 96 Medical Properties Trust shares in Q1 2026, an estimated $501.
  • Medical Properties Trust made up ﹤0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #814 holding.
  • Journey Strategic Wealth first reported a position in Medical Properties Trust in Q4 2023 and has held it in 9 quarters since.
  • Journey Strategic Wealth's Medical Properties Trust position peaked at $175K in Q1 2024.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.